News

Regulatory News:

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced

CI Global Asset Management (“CI GAM”) announces that CI Global Artificial Intelligence ETF (“CIAI”) has closed its initial offering of ETF C$ Series Units and begins trading today on the Toronto

CI Global Asset Management (“CI GAM”) today announced the appointment of CI Segall Bryant & Hamill Asset Management (“SBH”) as sub-advisor to US Equity Small Cap Pool and US Equity Small Cap

Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion systems, emissions control and water treatment in utility and industrial

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced

Mannatech, Incorporated (NASDAQ: MTEX), a leading global health and wellness company committed to transforming lives through Glycan technology, is thrilled to announce a significant milestone in

CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $474.2 billion as at March 31, 2024, consisting of asset management assets of $130.1 billion, Canadian wealth

CI Financial Corp. (“CI”) (TSX: CIX) will release its financial results for the first quarter of fiscal 2024 on Friday, May 10, 2024.

CI will hold a conference call with analysts that day at

Regulatory News:

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of

CI Global Asset Management (“CI GAM”) announced today it has completed the merger of 11 mutual funds into other mutual funds. CI GAM also confirmed it has implemented changes to the investment

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending April 30, 2024 in respect of the CI ETFs. In all cases, the distribution will be paid

Granite Real Estate Investment Trust (“Granite REIT”) and Granite REIT Inc. (“Granite GP” and, together with Granite REIT, “Granite”) (TSX: GRT.UN; NYSE: GRP.U) announced today that, at the

CI Financial Corp. (“CI”) (TSX: CIX) announced today it will hold its Annual Meeting of Shareholders on June 26, 2024 at 2:00 p.m. EDT.

The meeting will be held in a virtual-only format by way

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological

CI Global Asset Management (“CI GAM”) announced today that it has completed the mergers of eight mutual funds and exchange-traded funds into other mandates. CI GAM also announced the exchange

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) expects to announce its financial results for the first quarter ended March 31, 2024 after the close of markets on

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the final results of its substantial issuer bid (the “Offer”) under which it has purchased for cancellation

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has successfully obtained approval of certain previously announced amendments (the “Proposed Amendments”) from

Regulatory News:

GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing